Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 3/20 | 0.35 |
| ▸ | CLK1 | P49759 | 2/20 | 0.35 |
| ▸ | IKBKB | O14920 | 1/20 | 0.35 |
| ▸ | CHUK | O15111 | 1/20 | 0.35 |
| ▸ | CDC7 | O00311 | 1/20 | 0.35 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PRKCI | P41743 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21315925 | 0.75 | LIMK1 (0.36) | LIMK1CLK1 | |
| SCHEMBL26276459 | 0.72 | HPGD (0.34) | LIMK1CLK1IKBKBCHUKCDC7 | |
| SCHEMBL21315915 | 0.71 | — | — | |
| SCHEMBL19721360 | 0.69 | HPGD (0.36) | LIMK1CLK1IKBKBCHUKCDC7 | |
| SCHEMBL21315924 | 0.69 | CYP2A6 (0.33) | — | |
| SCHEMBL19721362 | 0.69 | HPGD (0.36) | LIMK1CLK1IKBKBCHUKCDC7 | |
| SCHEMBL4903332 | 0.67 | LIMK1 (0.50) | LIMK1CLK1IKBKBCHUKCDC7 | |
| SCHEMBL21315922 | 0.66 | KDM4E (0.41) | HPGDPIK3CAKDM4EALDH1A1 | |
| SCHEMBL19309704 | 0.59 | LIMK1 (0.35) | LIMK1CLK1IKBKBCHUKCDC7 | |
| SCHEMBL24623623 | 0.59 | LIMK1 (0.51) | LIMK1CLK1IKBKBCHUKCDC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10403826-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10403826-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | LIMK1 1839/4885CLK1 2668/4885IKBKB 4445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.